CCL20 and breast cancer: Key genes (CIRBP, INPP4B, IL6ST, and CCL20) were validated and linked to NAC response.<h4>Conclusion</h4>The cuproptosis-based risk score model effectively predicts NAC response and may guide personalized treatment in BC.